# FDA Inspection 674761 - US Oncology, Inc. IRB - July 28, 2010

Source: https://www.keypedia.com/records/fda_inspections/us-oncology-inc-irb/b0d4f12e-792f-444e-8ae9-2d46d3a8a53e
Source feed: FDA_Inspections

> FDA Inspection 674761 for US Oncology, Inc. IRB on July 28, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 674761
- Company Name: US Oncology, Inc. IRB
- Inspection Date: 2010-07-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1023482 - 2017-07-07](https://www.keypedia.com/records/fda_inspections/us-oncology-inc-irb/5bff253f-40c4-40c1-bbb0-bc302932b425)
- [FDA Inspection 569265 - 2009-03-12](https://www.keypedia.com/records/fda_inspections/us-oncology-inc-irb/68eeb987-42b8-459e-a06a-e346a118a32a)

Company: https://www.keypedia.com/companies/us-oncology-inc-irb/8d207e05-2aac-43c6-a6fd-6c3b94995997

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d